Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
Chang Cheng,
Jia Ruiying,
Fang Bin,
Miao Yaoyao,
Zhang Lili
Affiliations
Chang Cheng
General Surgery Department, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266011, China
Jia Ruiying
Surgical Center, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266011, China
Fang Bin
Colorectal Surgery Department, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, 266011, China
Miao Yaoyao
Pulmonary Disease Department, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, 266011, China
Zhang Lili
Imaging Department, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, 266011, China
This study aims to assess the potential mechanism of rutin to treat triple-negative breast cancer (TNBC) based on network pharmacology followed by in vitro experiments.
